Novartis | Marketskapitalisme



Market Capitalization Endring Dato
AbbVie USD 314.02B 34.8B 2024-12
Alcon AG CHF 38.43B 3.71B 2024-12
Almirall EUR 1.77B 232.92M 2024-12
Amgen USD 139.96B 33.39B 2024-12
AstraZeneca GBP 162.31B 17.34B 2024-12
Biogen USD 22.28B 5.95B 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Eli Lilly USD 732.87B 109.15B 2024-12
Fresenius EUR 18.89B 438.78M 2024-12
Fresenius Medical Care EUR 12.98B 1.75B 2024-12
Galapagos EUR 1.76B 51.29M 2024-12
Genmab DKK 98.78B 8.42B 2024-12
Gilead Sciences USD 115.09B 10.63B 2024-12
GlaxoSmithKline GBP 55.81B 7.05B 2024-12
J&J USD 348.19B 41.93B 2024-12
Lonza CHF 38.78B 3.36B 2024-12
Merck USD 251.65B 36.21B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Novo Nordisk A/S 2.12T 551.23B 2024-12
Orion EUR 6.03B 927.26M 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Philips EUR 23.05B 4.37B 2024-12
Regeneron Pharmaceuticals USD 78.28B 37.61B 2024-12
Sanofi EUR 118.41B 10.58B 2024-12



Novartis Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.